Comparing ways to give the covid-19 vaccine
Part of Immune system & allergy, Infections clinical trials.
This study tests two different ways of giving the covid-19 vaccine to see which one works better. It may help improve how vaccines are delivered in the future.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 50 years old.
- You are in good health, or have a stable chronic condition that hasn't changed in the last month.
- You have not had a covid-19 vaccine or covid-19 infection in the past year.
- You have not received any other vaccine in the last 60 days.
- You are willing to use effective birth control if you could become pregnant.
- You do not have certain health conditions like diabetes, heart disease, or a weakened immune system.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests updated COVID-19 vaccines designed to better protect against current variants. It's for people who have already been vaccinated and are at higher risk for severe COVID-19.
This study tests an updated mRNA COVID-19 vaccine to see how well it boosts immunity and how safe it is. It may help protect you from severe COVID-19 if you are older or have certain health conditions.
This study tests a new mRNA vaccine (called mRNA-1283) to protect against COVID-19 in children from 6 months to under 12 years old. It aims to see if the vaccine is safe and produces a good immune response.
This trial is testing whether a new mRNA vaccine that targets both seasonal flu and COVID-19 is safe and creates a strong immune response. It may offer an easier way to protect against two illnesses with one shot.
This study tests a higher dose of an experimental vaccine (VIR-1388) that may help prevent infection with cytomegalovirus (CMV), a common virus that can be harmful to people with weakened immune systems and to unborn babies. The vaccine is given to healthy adults who already have CMV to see if it is safe and produces a good immune response.
This study tests a new type of COVID-19 vaccine that is designed to train your immune system to make stronger, longer-lasting protection. You may be able to join if you are 40–64, have already had at least two doses of a mRNA COVID-19 vaccine (Pfizer or Moderna) more than 4 months ago, and are generally healthy.
Hear when a new SARS CoV-2 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.